Molecure S.A.

WSE:MOC Stok Raporu

Piyasa değeri: zł210.1m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Molecure Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Marcin Szumowski

İcra Kurulu Başkanı

zł473.2k

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresino data
CEO sahipliği0.7%
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi2.8yrs

Son yönetim güncellemeleri

Recent updates

Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Aug 20
Is Molecure (WSE:MOC) In A Good Position To Deliver On Growth Plans?

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Apr 20
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Dec 01
We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate

Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Jul 07
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Mar 10
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

Aug 16
Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth

OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Nov 04
OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem

Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Feb 24
Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?

Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

Jan 02
Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?

CEO

Marcin Szumowski

no data

Görev süresi

zł473,205

Tazminat

Dr. Marcin Jan Szumowski, Ph D., is employed at Life Science Innovations Fund. He has been Chief Executive Officer and President of the Management Board at Molecure S.A. (formerly known as OncoArendi Thera...

Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Marcin Szumowski
Co-Founderno datazł473.21k0.70%
PLN 1.5m
Slawomir Broniarek
CFO & Member of the Management Boardno datazł421.09k0.20%
PLN 430.6k
Zbigniew Zaslona
Chief Scientific Officer & Member of Management Board2.8yrszł473.21k0.11%
PLN 235.7k
Agnieszka Rajczuk-Szczepanska
Member of Management Board & HR Director4.8yrszł348.41k0.034%
PLN 72.4k
Samson Fung
Chief Medical Officer & Member of Management Board1.8yrszł999.47kVeri yok
Adam Golebiowski
Co-Founder & VP of Research Chemistry12.8yrszł500.00k3.01%
PLN 6.3m
Jacek Olczak
Co-Founder & Head of Medicinal Chemistryno dataVeri yokVeri yok
Magdalena Tyszkiewicz
Head of CMC4.8yrsVeri yokVeri yok
Marta Borkowska
Director of the Management Board Office2.8yrsVeri yokVeri yok

3.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim: MOC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).

Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Luke O'Neill
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Reynold A. Panettieri
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Bart Lambrecht
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Tomasz Piec
Vice Chairman of the Supervisory Board4.8yrszł133.62kVeri yok
Douglas Hay
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Paul Van Der Horst
Independent Chairman of the Supervisory Board2.8yrszł132.99k0.059%
PLN 124.8k
Nancy Van Osselaer
Independent Member of the Supervisory Board2.8yrszł124.22kVeri yok
Agnieszka Motyl
Member of the Supervisory Board1.3yrszł44.45kVeri yok
Pawel Trawkowski
Independent Member of the Supervisory Board2.3yrszł124.22kVeri yok

2.8yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: MOC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilmiyor ( 2.8 yıllık ortalama görev süresi), bu da yeni bir yönetim kurulu olduğunu gösteriyor.